Brian Dorsey, Chief Operating Officer at ARS Pharmaceuticals, Inc. (SPRY), sold 50,000 shares at $15.00 ($750K) on 2024-08-20, disclosed to the SEC on 2024-08-21.
Scheduled sale ($750k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SPRY | SELL | 2024-08-15 | $390K | — | Filing → |
| APRI | BUY | 2014-12-30 | $11K | — | Filing → |
| SOMX | SELL | 2012-01-04 | $4K | — | Filing → |